| Agranulocytosis associated with cocaine use-four States, March 2008-November 2009. M Brackney, J Baumbach, C Ewers, AL Martinez, J Hagan, D Czuchlewski, ... Morbidity and Mortality Weekly Report 58 (49), 1381-1385, 2009 | 157 | 2009 |
| Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine DR Czuchlewski, M Brackney, C Ewers, J Manna, MH Fekrazad, ... American Journal of Clinical Pathology 133 (3), 466-472, 2010 | 109 | 2010 |
| A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma JE Bauman, H Arias-Pulido, SJ Lee, MH Fekrazad, H Ozawa, E Fertig, ... Oral oncology 49 (5), 461-467, 2013 | 107 | 2013 |
| Response of intracranial metastases to erlotinib therapy MH Fekrazad, M Ravindranathan, DV Jones Jr Journal of clinical oncology 25 (31), 5024-5026, 2007 | 79 | 2007 |
| Breast disease: benign and malignant ALW Meisner, MH Fekrazad, ME Royce Medical Clinics of North America 92 (5), 1115-1141, 2008 | 73 | 2008 |
| Epstein–Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature L Rosenbaum, MH Fekrazad, I Rabinowitz, MA Vasef Journal of hematopathology 2, 127-131, 2009 | 63 | 2009 |
| A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies J Bauman, C Verschraegen, S Belinsky, C Muller, T Rutledge, ... Cancer chemotherapy and pharmacology 69, 547-554, 2012 | 61 | 2012 |
| Treatment of venous thromboembolism: guidelines translated for the clinician M Houman Fekrazad, RD Lopes, GJ Stashenko, JH Alexander, D Garcia Journal of thrombosis and thrombolysis 28, 270-275, 2009 | 39 | 2009 |
| A phase I protocol of hydralazine and valproic acid in advanced, previously treated solid cancers J Bauman, M Shaheen, CF Verschraegen, SA Belinsky, MH Fekrazad, ... Translational oncology 7 (3), 349-354, 2014 | 34 | 2014 |
| Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups E Libby, D Garcia, D Quintana, MH Fekrazad, J Bauman, A Ebaid, ... Leukemia & Lymphoma 55 (12), 2850-2857, 2014 | 26 | 2014 |
| Anaplastic large cell lymphoma associated with breast implants S Ravi-Kumar, O Sanaei, M Vasef, I Rabinowitz, MH Fekrazad World Journal of Plastic Surgery 1 (1), 30, 2012 | 21 | 2012 |
| Phase II trial using a combination of oxaliplatin, capecitabine, and celecoxib with concurrent radiation for newly diagnosed resectable rectal cancer EP Araujo‐Mino, YZ Patt, C Murray‐Krezan, JA Hanson, P Bansal, ... The oncologist 23 (1), 2-e5, 2018 | 20 | 2018 |
| Development of bronchiolitis obliterans organizing pneumonia with platinum-based chemotherapy for metastatic rectal cancer MH Fekrazad, S Eberhardt, DV Jones, FC Lee Clinical colorectal cancer 9 (3), 177-178, 2010 | 20 | 2010 |
| Hypokalemia secondary to capecitabine: a hidden toxicity? MW Saif, MH Fekrazad, L Ledbetter, RB Diasio Therapeutics and Clinical Risk Management 3 (1), 177-180, 2007 | 12 | 2007 |
| Phase II study of temsirolimus and erlotinib in patients (pts) with recurrent/metastatic (R/M), platinum-refractory head and neck squamous cell carcinoma (HNSCC). JE Bauman, H Arias-Pulido, SJ Lee, M Considine, MH Fekrazad, ... Journal of Clinical Oncology 30 (15_suppl), 5549-5549, 2012 | 7 | 2012 |
| Hypertrophic lichen planus mimicking squamous cell carcinoma of skin W Murad, MH Fekrazad Journal of Osteopathic Medicine 114 (9), 735-735, 2014 | 4 | 2014 |
| Enfermedades mamarias: benignas y malignas ALW Meisner, MH Fekrazad, ME Royce Clínicas médicas de Norteamérica 92 (5), 1115-1141, 2008 | 4 | 2008 |
| Phase II trial of sorafenib (S) and capecitabine (C) for hepatocellular carcinoma (HCC) in cirrhotic patients (pts). CM Rojas-Hernandez, YZ Patt, MH Fekrazad, KA Steinberg, M Roach, ... Journal of Clinical Oncology 31 (15_suppl), e15136-e15136, 2013 | 3 | 2013 |
| Spontaneous regression of high grade primary gastric Lymphoma in an untreated viral hepatitis infection CM Rojas-Hernandez, JF Coleman, DR Czuchlewski, MH Fekrazad Leukemia & Lymphoma 55 (11), 2643-2645, 2014 | 2 | 2014 |
| Sorafenib and Capecitabine for hepatocellular carcinoma (HCC), a phase II trial Y Patt, C Rojas-Hernandez, M Fekrazad, K Steinberg, M Roach, FC Lee Annals of oncology 24, iv45, 2013 | 2 | 2013 |
